Cargando…

First human efficacy study of a plant-derived influenza vaccine

Detalles Bibliográficos
Autor principal:	Tregoning, John S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553753/ https://www.ncbi.nlm.nih.gov/pubmed/33065033 http://dx.doi.org/10.1016/S0140-6736(20)32010-9

Ejemplares similares

Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines
por: Altmann, Daniel M, et al.
Publicado: (2022)

Respiratory syncytial virus after the SARS-CoV-2 pandemic — what next?
por: Mosscrop, Lucy G., et al.
Publicado: (2022)

Redirected vaccine imprinting by co-administration of COVID-19 and influenza vaccines
por: Boyton, Rosemary J., et al.
Publicado: (2023)

COVID-19 vaccines: breaking record times to first-in-human trials
por: Kim, Young Chan, et al.
Publicado: (2020)

How repeated influenza vaccination effects might apply to COVID-19 vaccines
por: Thompson, Mark G, et al.
Publicado: (2022)

Influenza vaccination and healthcare utilization in asthma: a Canadian experience
por: Moitra, Subhabrata, et al.
Publicado: (2023)

Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemma
por: Mehta, Puja, et al.
Publicado: (2021)

First clinical trial of a MERS coronavirus DNA vaccine
por: Yoon, In-Kyu, et al.
Publicado: (2019)

Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?
por: Modjarrad, Kayvon, et al.
Publicado: (2020)

COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room
por: Olliaro, Piero, et al.
Publicado: (2021)

Oxford–AstraZeneca COVID-19 vaccine efficacy
por: Knoll, Maria Deloria, et al.
Publicado: (2021)

Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
por: Bird, Sarah, et al.
Publicado: (2021)

Genomic surveillance of avian-origin influenza A viruses causing human disease
por: Lam, Tommy T., et al.
Publicado: (2018)

New international guidance on quality, safety and efficacy of DNA vaccines
por: Beasley, David W. C.
Publicado: (2020)

COVID-19 vaccine trials should seek worthwhile efficacy
por: Krause, Philip, et al.
Publicado: (2020)

Predicting the efficacy of new coronavirus vaccines – Are neutralising antibodies enough?
por: Miller, Elizabeth
Publicado: (2022)

Impact of methotrexate on first-dose COVID-19 mRNA vaccination
por: Connolly, Caoilfhionn M, et al.
Publicado: (2021)

Could a good night's sleep improve COVID-19 vaccine efficacy?
por: Benedict, Christian, et al.
Publicado: (2021)

SARS-CoV-2 vaccines: fast track versus efficacy
por: Alkandari, Dana, et al.
Publicado: (2021)

Single-dose SARS-CoV-2 vaccination efficacy in the elderly
por: Prendecki, Maria, et al.
Publicado: (2021)

What can we expect from first-generation COVID-19 vaccines?
por: Peiris, Malik, et al.
Publicado: (2020)

Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
por: Boekel, Laura, et al.
Publicado: (2021)

The influenza imperative: we must prepare now for seasonal and pandemic influenza
por: Dzau, Victor, et al.
Publicado: (2023)

Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine
por: Kennedy, Richard B
Publicado: (2022)

COVID-19 vaccines for the older population: safety and efficacy go hand in hand
por: Zheng, Hui, et al.
Publicado: (2022)

COVID-19 is not influenza
por: Petersen, Eskild
Publicado: (2021)

Microbial antigen in human milk: a natural vaccine?
por: van den Elsen, Lieke W. J., et al.
Publicado: (2022)

A new dawn for the management of influenza?
por: Tillotson, Glenn S
Publicado: (2020)

Mandatory COVID-19 vaccination and human rights
por: King, Jeff, et al.
Publicado: (2022)

Human papillomavirus vaccination for young survivors of cancer
por: Brewer, Noel T, et al.
Publicado: (2022)

The growing threat of wild poliovirus 1 and vaccine-derived cases in the COVID-19 era
por: Franco-Paredes, Carlos, et al.
Publicado: (2022)

Influenza Vaccination of Healthcare Workers Is an Important Approach for Reducing Transmission of Influenza from Staff to Vulnerable Patients
por: Hayward, Andrew C.
Publicado: (2017)

COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA
por: Krantz, Matthew S, et al.
Publicado: (2022)

What could fair allocation of an efficacious COVID-19 vaccine look like in South Africa?
por: Moodley, Keymanthri, et al.
Publicado: (2021)

Global emergence of SARS-CoV-2 variants: new foresight needed for improved vaccine efficacy
por: Yadav, Pragya D, et al.
Publicado: (2022)

Health-care workers in influenza pandemics
por: Nash, Robert
Publicado: (2007)

Vaccine-derived polio in Peru after 32 years of elimination: reflections on the routine childhood immunisation coverages
por: Al-kassab-Córdova, Ali, et al.
Publicado: (2023)

Emergence of rabies among vaccinated humans in India: a public health concern
por: Goel, Kapil, et al.
Publicado: (2022)

We need to keep an eye on avian influenza
por: Krammer, Florian, et al.
Publicado: (2023)

Mouse Models of Influenza Infection with Circulating Strains to Test Seasonal Vaccine Efficacy
por: Groves, Helen T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cuprj81dj52b38k615v8jfsmdc